The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Geriatric Medicine-Global Market Insights and Sales Trends 2024
Synopsis
The global Geriatric Medicine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Geriatric Medicine in various end use industries. The expanding demands from the Cardiovascular, Arthritis, Neurological and Cancer, are propelling Geriatric Medicine market. Analgesics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antihypertensives segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Geriatric Medicine market, driven by demand from China, the second largest economy with some signs of stabilising, the Geriatric Medicine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Geriatric Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Geriatric Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Geriatric Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Geriatric Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Geriatric Medicine covered in this report include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca and Merck, etc.
The global Geriatric Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Boehringer Ingelheim
Novartis
Bristol-Myers Squibb
Pfizer
Eli Lilly
Abbott
AstraZeneca
Merck
Sanofi S.A.
Global Geriatric Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Geriatric Medicine market, Segment by Type:
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant
Global Geriatric Medicine market, by Application
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Geriatric Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Geriatric Medicine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Geriatric Medicine in various end use industries. The expanding demands from the Cardiovascular, Arthritis, Neurological and Cancer, are propelling Geriatric Medicine market. Analgesics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antihypertensives segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Geriatric Medicine market, driven by demand from China, the second largest economy with some signs of stabilising, the Geriatric Medicine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Geriatric Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Geriatric Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Geriatric Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Geriatric Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Geriatric Medicine covered in this report include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca and Merck, etc.
The global Geriatric Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Boehringer Ingelheim
Novartis
Bristol-Myers Squibb
Pfizer
Eli Lilly
Abbott
AstraZeneca
Merck
Sanofi S.A.
Global Geriatric Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Geriatric Medicine market, Segment by Type:
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant
Global Geriatric Medicine market, by Application
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Geriatric Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Geriatric Medicine
1.1 Geriatric Medicine Market Overview
1.1.1 Geriatric Medicine Product Scope
1.1.2 Geriatric Medicine Market Status and Outlook
1.2 Global Geriatric Medicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Geriatric Medicine Market Size by Region (2018-2029)
1.4 Global Geriatric Medicine Historic Market Size by Region (2018-2023)
1.5 Global Geriatric Medicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Geriatric Medicine Market Size (2018-2029)
1.6.1 North America Geriatric Medicine Market Size (2018-2029)
1.6.2 Europe Geriatric Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Geriatric Medicine Market Size (2018-2029)
1.6.4 Latin America Geriatric Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Geriatric Medicine Market Size (2018-2029)
2 Geriatric Medicine Market by Type
2.1 Introduction
2.1.1 Analgesics
2.1.2 Antihypertensives
2.1.3 Statins
2.1.4 Antidiabetics
2.1.5 Proton Pump Inhibitor
2.1.6 Anticoagulant
2.1.7 Antipsychotic
2.1.8 Antidepressant
2.2 Global Geriatric Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Geriatric Medicine Historic Market Size by Type (2018-2023)
2.2.2 Global Geriatric Medicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Geriatric Medicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Geriatric Medicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Geriatric Medicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Geriatric Medicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Geriatric Medicine Revenue Breakdown by Type (2018-2029)
3 Geriatric Medicine Market Overview by Application
3.1 Introduction
3.1.1 Cardiovascular
3.1.2 Arthritis
3.1.3 Neurological
3.1.4 Cancer
3.1.5 Osteoporosis
3.1.6 Respiratory
3.2 Global Geriatric Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Geriatric Medicine Historic Market Size by Application (2018-2023)
3.2.2 Global Geriatric Medicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Geriatric Medicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Geriatric Medicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Geriatric Medicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Geriatric Medicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Geriatric Medicine Revenue Breakdown by Application (2018-2029)
4 Geriatric Medicine Competition Analysis by Players
4.1 Global Geriatric Medicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Geriatric Medicine as of 2022)
4.3 Date of Key Players Enter into Geriatric Medicine Market
4.4 Global Top Players Geriatric Medicine Headquarters and Area Served
4.5 Key Players Geriatric Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Geriatric Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Geriatric Medicine Products, Services and Solutions
5.1.4 GSK Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Profile
5.2.2 Boehringer Ingelheim Main Business
5.2.3 Boehringer Ingelheim Geriatric Medicine Products, Services and Solutions
5.2.4 Boehringer Ingelheim Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.2.5 Boehringer Ingelheim Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Geriatric Medicine Products, Services and Solutions
5.3.4 Novartis Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Geriatric Medicine Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Geriatric Medicine Products, Services and Solutions
5.5.4 Pfizer Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Geriatric Medicine Products, Services and Solutions
5.6.4 Eli Lilly Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 Abbott
5.7.1 Abbott Profile
5.7.2 Abbott Main Business
5.7.3 Abbott Geriatric Medicine Products, Services and Solutions
5.7.4 Abbott Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.7.5 Abbott Recent Developments
5.8 AstraZeneca
5.8.1 AstraZeneca Profile
5.8.2 AstraZeneca Main Business
5.8.3 AstraZeneca Geriatric Medicine Products, Services and Solutions
5.8.4 AstraZeneca Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.8.5 AstraZeneca Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck Geriatric Medicine Products, Services and Solutions
5.9.4 Merck Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.9.5 Merck Recent Developments
5.10 Sanofi S.A.
5.10.1 Sanofi S.A. Profile
5.10.2 Sanofi S.A. Main Business
5.10.3 Sanofi S.A. Geriatric Medicine Products, Services and Solutions
5.10.4 Sanofi S.A. Geriatric Medicine Revenue (US$ Million) & (2018-2023)
5.10.5 Sanofi S.A. Recent Developments
6 North America
6.1 North America Geriatric Medicine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Geriatric Medicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Geriatric Medicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Geriatric Medicine Market Dynamics
11.1 Geriatric Medicine Industry Trends
11.2 Geriatric Medicine Market Drivers
11.3 Geriatric Medicine Market Challenges
11.4 Geriatric Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
